Title |
Clinical and echocardiographic outcomes of combined CABG and MV repair
|
Authors |
Rajat Sindwani1, Gurmeet Singh1, Harneet Singh Khurana3,*, Samir Kapoor1, Vikrampal Singh1, Sarju Ralhan1, Rajesh Chand Arya1 & Rajiv Kumar Gupta2
|
Affiliation |
1Department of Cardiothoracic and Vascular Surgery, Hero Heart DMC Institute, Ludhiana, Punjab, India; 2Department of Cardiothoracic and Vascular Surgery, All India Institute of Medical Sciences, Bathinda, Punjab, India; 3Department of Anaesthesia, Dayanand Medical College and Hospital, Ludhiana, Punjab, India; *Corresponding author
|
|
Rajat Sindwani - E-mail: rajat_sindwani@hotmail.com
Gurmeet Singh - E-mail: drgurmeetsingh1979@gmail.com
|
Article Type |
Research Article
|
Date |
Received July 1, 2025; Revised July 31, 2025; Accepted July 31, 2025, Published July 31, 2025
|
Abstract |
A mixed-method observational study evaluated patients undergoing Coronary Artery Bypass Grafting (CABG) with mitral valve (MV) repair for moderate to severe mitral regurgitation (MR). Most patients aged between 61–70 years (46.3%) and with 60% being male, 73% with Type 2 diabetes and 83.33% with triple-vessel coronary artery disease (CAD) (83.8%) and 15% with left main CAD. At discharge, 94.7% improved to NYHA class II and residual MR was eliminated in 97.1% patients. This study demonstrates significantly improved 12-month outcomes, with elimination of residual MR, supporting CABG with concomitant MV repair as a viable option for IMR patients despite high comorbidity. |
Keywords |
Effective regurgitant orifice area, New York Heart Association (NYHA), secondary mitral regurgitation, ischemic heart disease and coronary artery bypasses grafting.
|
Citation |
Sindwani et al. Bioinformation 21(7): 2133-2139 (2025)
|
Edited by |
P Kangueane
|
ISSN |
0973-2063
|
Publisher |
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|